NASDAQ

Scienture Holdings, Inc. (SCNX)

477 Thanks from members

Scienture Holdings, Inc. (SCNX) shows mixed market sentiment with a micro-cap valuation around $15M to $18M, recent positive news regarding GPO agreements for REZENOPY Naloxone spray driving short-term stock spikes, and conflicting fundamental quality scores.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →